Radiotherapy activates picolinium prodrugs in tumours

Radiotherapy-induced prodrug activation provides an ideal solution to reduce the systemic toxicity of chemotherapy in cancer therapy, but the scope of the radiation-activated protecting groups is limited. Here we present that the well-established photoinduced electron transfer chemistry may pave the...

Full description

Saved in:
Bibliographic Details
Published inNature chemistry Vol. 16; no. 8; pp. 1348 - 1356
Main Authors Fu, Qunfeng, Gu, Zhi, Shen, Siyong, Bai, Yifei, Wang, Xianglin, Xu, Mengxin, Sun, Pengwei, Chen, Junyi, Li, Dongxuan, Liu, Zhibo
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Radiotherapy-induced prodrug activation provides an ideal solution to reduce the systemic toxicity of chemotherapy in cancer therapy, but the scope of the radiation-activated protecting groups is limited. Here we present that the well-established photoinduced electron transfer chemistry may pave the way for developing versatile radiation-removable protecting groups. Using a functional reporter assay, N-alkyl-4-picolinium (NAP) was identified as a caging group that efficiently responds to radiation by releasing a client molecule. When evaluated in a competition experiment, the NAP moiety is more efficient than other radiation-removable protecting groups discovered so far. Leveraging this property, we developed a NAP-derived carbamate linker that releases fluorophores and toxins on radiation, which we incorporated into antibody-drug conjugates (ADCs). These designed ADCs were active in living cells and tumour-bearing mice, highlighting the potential to use such a radiation-removable protecting group for the development of next-generation ADCs with improved stability and therapeutic effects.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1755-4330
1755-4349
1755-4349
DOI:10.1038/s41557-024-01501-4